Kite Pharma, Inc. Insider Trading for July 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for July 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Option Exercise | M | 1.35 | 15,000 | 20,250 | 95,394 | |
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 105.50 | 5,000 | 527,500 | 117,795 | 122.8 K to 117.8 K (-4.07 %) |
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 102.81 | 1,100 | 113,091 | 122,795 | 123.9 K to 122.8 K (-0.89 %) |
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 102.19 | 5,553 | 567,461 | 123,895 | 129.4 K to 123.9 K (-4.29 %) |
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 101.06 | 3,347 | 338,248 | 129,448 | 132.8 K to 129.4 K (-2.52 %) |
| Jul 11 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Buy | M | 1.35 | 15,000 | 20,250 | 132,795 | 117.8 K to 132.8 K (+12.73 %) |
| Jul 06 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 10,000 | 68,900 | 58,000 | |
| Jul 06 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 104.76 | 1,201 | 125,817 | 21,071 | 22.3 K to 21.1 K (-5.39 %) |
| Jul 06 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 104.26 | 8,799 | 917,384 | 22,272 | 31.1 K to 22.3 K (-28.32 %) |
| Jul 06 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 10,000 | 68,900 | 31,071 | 21.1 K to 31.1 K (+47.46 %) |